======= DHFRL1 =======
== Gene Information ==
* **Official Symbol**: DHFR2
* **Official Name**: dihydrofolate reductase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=200895|200895]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86XF0|Q86XF0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DHFRL1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DHFRL1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616588|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Binds its own mRNA and that of DHFR. {ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:21876188}.
|DHFR 1|
|deoxyribonucleoside biosynthetic process|
|dihydrofolate reductase activity|
|pyrimidine deoxyribonucleoside biosynthetic process|
|thymidine biosynthetic process|
|dihydrofolate metabolic process|
|pyrimidine deoxyribonucleoside metabolic process|
|thymidine metabolic process|
|tetrahydrofolate biosynthetic process|
|deoxyribonucleoside metabolic process|
|folic acid-containing compound biosynthetic process|
|pteridine-containing compound biosynthetic process|
|pyrimidine nucleoside biosynthetic process|
|tetrahydrofolate metabolic process|
|folic acid metabolic process|
|one-carbon metabolic process|
|folic acid-containing compound metabolic process|
|pteridine-containing compound metabolic process|
|NADP binding|
|pyrimidine nucleoside metabolic process|
|nucleoside biosynthetic process|
|glycosyl compound biosynthetic process|
|cellular modified amino acid biosynthetic process|
|pyrimidine-containing compound biosynthetic process|
|water-soluble vitamin metabolic process|
|dicarboxylic acid metabolic process|
|nucleobase-containing small molecule biosynthetic process|
|pyrimidine-containing compound metabolic process|
|nucleoside metabolic process|
|vitamin metabolic process|
|glycosyl compound metabolic process|
|coenzyme biosynthetic process|
|mRNA binding|
|cellular modified amino acid metabolic process|
|cofactor biosynthetic process|
|coenzyme metabolic process|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|mitochondrial matrix|
|mitochondrial inner membrane|
|cofactor metabolic process|
|drug metabolic process|
|amide biosynthetic process|
|nucleobase-containing small molecule metabolic process|
|small molecule biosynthetic process|
|carbohydrate derivative biosynthetic process|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|mitochondrion|
|organic cyclic compound biosynthetic process|
|organonitrogen compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.75|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.469|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2393
* **Expression level (log2 read counts)**: 3.98
{{:chemogenomics:nalm6 dist.png?nolink |}}